These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19834445)

  • 21. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles of quantitative positron emission tomography.
    van den Hoff J
    Amino Acids; 2005 Dec; 29(4):341-53. PubMed ID: 16003499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance evaluation of a high-sensitivity large-aperture small-animal PET scanner: ClairvivoPET.
    Mizuta T; Kitamura K; Iwata H; Yamagishi Y; Ohtani A; Tanaka K; Inoue Y
    Ann Nucl Med; 2008 Jun; 22(5):447-55. PubMed ID: 18600425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET and PET/CT studies of tumor tissue oxygenation.
    Krause BJ; Beck R; Souvatzoglou M; Piert M
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):28-43. PubMed ID: 16557202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of standard uptake value in dual-head coincidence system.
    Geng J; Chen Y; Chen S; Si H; Tian J
    Biomed Mater Eng; 2007; 17(4):219-27. PubMed ID: 17611297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fast high performance liquid chromatography in PET quality control and metabolite analysis.
    Passchier J
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):411-6. PubMed ID: 19834451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-animal PET: what is it, and why do we need it?
    Yao R; Lecomte R; Crawford ES
    J Nucl Med Technol; 2012 Sep; 40(3):157-65. PubMed ID: 22582006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fundamentals of positron emission tomography and applications in preclinical drug development.
    Cherry SR
    J Clin Pharmacol; 2001 May; 41(5):482-91. PubMed ID: 11361044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Realizing the full potential of PET for measuring the biodistribution of novel anticancer agents.
    Jones T; Price P; Tavitian B
    J Nucl Med; 2011 Sep; 52(9):1500. PubMed ID: 21824989
    [No Abstract]   [Full Text] [Related]  

  • 30. Positron Emission Tomography: applications in drug discovery and drug development.
    Wang J; Maurer L
    Curr Top Med Chem; 2005; 5(11):1053-75. PubMed ID: 16181131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of small animal PET for molecular imaging in pre-clinical studies.
    Nanni C; Rubello D; Fanti S
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1819-22. PubMed ID: 17351773
    [No Abstract]   [Full Text] [Related]  

  • 32. Harnessing Preclinical Molecular Imaging to Inform Advances in Personalized Cancer Medicine.
    Clark PM; Ebiana VA; Gosa L; Cloughesy TF; Nathanson DA
    J Nucl Med; 2017 May; 58(5):689-696. PubMed ID: 28385796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the Input Function at the Entry of the Tissue of Interest and Its Impact on PET Kinetic Modeling Parameters.
    Bentourkia M
    Mol Imaging Biol; 2015 Dec; 17(6):748-56. PubMed ID: 26395903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Criteria for the design and biological characterization of radiolabeled peptide-based pharmaceuticals.
    Benedetti E; Morelli G; Accardo A; Mansi R; Tesauro D; Aloj L
    BioDrugs; 2004; 18(5):279-95. PubMed ID: 15377171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug development, radiolabelled drugs and PET.
    Vaalburg W; Hendrikse NH; de Vries EF
    Ann Med; 1999 Dec; 31(6):432-7. PubMed ID: 10680858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Theoretic prediction of drug safety and efficacy--drug efficacy].
    Ito T; Nakajima M
    Nihon Yakurigaku Zasshi; 1996 Sep; 108(3):175-7. PubMed ID: 9091455
    [No Abstract]   [Full Text] [Related]  

  • 37. Instrumentation and methodology for quantitative pre-clinical imaging studies.
    Meikle SR; Eberl S; Iida H
    Curr Pharm Des; 2001 Dec; 7(18):1945-66. PubMed ID: 11772359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracer Kinetic Modeling in PET.
    Bentourkia M; Zaidi H
    PET Clin; 2007 Apr; 2(2):267-77. PubMed ID: 27157877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in biomathematical modeling for PET neuroreceptor imaging.
    Gunn RN; Guo Q; Salinas CA; Tziortzi AC; Searle GE
    Drug Discov Today Technol; 2011; 8(2-4):e45-51. PubMed ID: 24990262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep learning generation of preclinical positron emission tomography (PET) images from low-count PET with task-based performance assessment.
    Dutta K; Laforest R; Luo J; Jha AK; Shoghi KI
    Med Phys; 2024 Jun; 51(6):4324-4339. PubMed ID: 38710222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.